Targeted Muscle Reinnervation (TMR) for Amputees: A Patient's Guide

Written by Brian P. Kelley, MD — Dual Board-Certified Plastic & Hand Surgeon
Affiliate Faculty, Dell Medical School at The University of Texas at Austin
Seton Ascension Institute for Reconstructive Plastic and Hand Surgery
‍Medically reviewed: May 25, 2026 · Last updated: May 25, 2026
Educational content. Not a substitute for individualized medical evaluation.

Introduction

For many amputees, the hardest part of life after amputation is not the absence of the limb — it is the pain. Phantom limb pain and residual limb pain affect a large proportion of amputees, can be severe and persistent, and have historically been managed mostly with medications that work inconsistently. Targeted Muscle Reinnervation, or TMR, is a surgical technique that addresses the root cause of much of this pain, and the evidence supporting it has grown strong enough that it is now considered a first-line surgical option for amputation-related pain at many centers.

I trained in plastic surgery, microsurgery, and hand surgery at the University of Michigan, a program with deep roots in peripheral nerve surgery, and peripheral nerve work — including nerve transfers and the management of amputation-related pain — has remained central to my practice and my published research.¹ I now practice as a double board-certified plastic and hand surgeon in Austin, Texas, as an Affiliate Faculty Professor at Dell Medical School at The University of Texas at Austin, and as a partner at the Seton Ascension Institute for Reconstructive Plastic and Hand Surgery. This guide explains what TMR is, how the surgery works, what recovery looks like, and what the published patient-reported outcomes data show about how well it works and what its risks are.

The Problem TMR Solves

When a limb is amputated, the major nerves that once traveled to the hand or foot are cut. A cut nerve does not simply stop functioning — it tries to regenerate, sending out new nerve fibers in search of a target. With no target to reach, those fibers form a disorganized, hyperexcitable tangle called a neuroma. Neuromas are a major source of two debilitating problems: residual limb pain (pain in the remaining part of the limb, often at the neuroma itself) and phantom limb pain (pain perceived in the missing part of the limb).

These are not rare. Phantom limb pain has been estimated to affect a majority of amputees, and residual limb pain is also common. Historically, treatment relied on medications — including opioids — that often provided inconsistent relief, and on older surgical approaches like cutting the nerve shorter or burying it in muscle, which were palliative and did not address why the neuroma formed.

TMR works differently. It gives the cut nerve somewhere to go and something to do.

What TMR Surgery Is

Targeted Muscle Reinnervation transfers a divided major nerve to a nearby, smaller motor nerve branch that supplies an expendable muscle. The surgeon identifies a small motor nerve entering a muscle that is no longer functionally essential after the amputation, divides that small motor branch, and connects the large cut nerve to it under magnification. The cut nerve's regenerating fibers then grow into the existing motor nerve pathway and reinnervate the target muscle, which becomes their new destination.

This accomplishes two things. First, it prevents or treats the painful neuroma, because the nerve now has an organized target instead of forming a disorganized tangle. Second, it creates new, amplified electrical signals in the reinnervated muscle that can be used to control advanced myoelectric prosthetic devices — TMR was originally developed for prosthetic control, and the pain benefit was recognized from that early work.

TMR can be performed in two settings:

Primary (prophylactic) TMR is done at the time of amputation. The nerves are managed immediately, before a neuroma forms. This is increasingly the preferred approach when an amputation is planned, because preventing the neuroma produces better results than treating one later.

Secondary (therapeutic) TMR is done months or years after amputation, in a patient who has already developed a symptomatic neuroma or chronic pain. The neuroma is removed and the freshened nerve is transferred. This is effective and worthwhile, though outcomes are generally somewhat better with primary surgery.

How TMR Differs From Older Approaches

The contrast with traditional neuroma management is the key to understanding why TMR has changed the field. Older techniques — excising the neuroma and burying the nerve end in muscle or bone, or simply cutting the nerve and allowing it to retract — did not give the nerve a target, so the underlying biological driver of the pain remained. Neuromas frequently recurred.

A landmark randomized controlled trial compared TMR against the conventional approach of neuroma excision and muscle burying, and found that TMR reduced postamputation pain relative to the conventional treatment. This was the level of evidence that moved TMR from a promising idea to a recommended technique. Subsequent prospective studies have reinforced it.

Recovery and Healing Timeline

A point that matters enormously for setting expectations: TMR relief develops over months, not days, because it depends on nerve regeneration, which is inherently slow.

The operation and immediate recovery. When TMR is done at the time of amputation, it adds time to the amputation surgery but does not fundamentally change the amputation recovery. When done as a secondary procedure, it is its own operation, often outpatient or short-stay, with incisional healing over the first couple of weeks.

The incision versus the nerve. As with other nerve operations, surgical healing and nerve healing follow different timelines. The incision heals in weeks. The nerve transfer, however, requires the cut nerve's fibers to grow into the target muscle and reinnervate it — a process that advances slowly (on the order of about a millimeter per day) and reorganizes over months. Pain relief tracks the nerve reorganization, not the incision, so a patient whose incision has healed at three weeks may still have significant pain that improves over the following months.

The trajectory of relief. In the prospective studies, pain scores improve over the first year, and — importantly — the relief is durable. A longitudinal study following patients for an average of 2.4 years, with some beyond 18 months, found that the pain improvements after TMR at the time of amputation were sustained over time rather than fading.² This durability is one of the most clinically meaningful findings, because it distinguishes TMR from treatments that provide only temporary relief.

Prosthetic rehabilitation. For patients using the reinnervated muscle signals for myoelectric prosthetic control, rehabilitation with a prosthetist and therapy team is its own process that unfolds over months as the patient learns to use the new control signals.

What the Patient-Reported Outcomes Data Show

The evidence for TMR is unusually strong for a surgical technique, and it is heavily weighted toward patient-reported outcomes — what patients themselves report about their pain and function, measured with validated instruments.

A prospective study of 33 major limb amputees used the PROMIS (Patient-Reported Outcomes Measurement Information System) pain intensity and pain interference measures and found that TMR improved residual limb pain and phantom limb pain, concluding that TMR should be considered a first-line surgical treatment option for chronic amputation-related pain in major limb amputees.³ This study is notable because it measured pain the way the patient experiences it, not just clinical observation.

The longitudinal durability study mentioned above followed 81 patients with 83 treated limbs, using numeric rating scale pain scores and PROMIS pain interference and pain behavior measures, and demonstrated that the pain relief was sustained over an average of 2.4 years.² A systematic review and meta-analysis pooling data across multiple studies found clinically meaningful reductions in both residual limb pain and phantom limb pain in favor of TMR, with pooled reductions of roughly two to three points on standard pain scales.

In the oncologic amputee population — patients who lose a limb as part of cancer treatment, a group with particularly high pain and opioid burden — a cohort study found that TMR and the related RPNI technique were safe and were associated with significant reductions in residual limb pain and phantom limb pain, along with improvements in patient-reported outcomes. In that study, patient opioid use decreased from approximately 86% before surgery to approximately 38% afterward.⁴

The honest caveats: while there is one foundational randomized controlled trial, much of the supporting evidence consists of prospective cohort studies and systematic reviews of them. Outcome measures and follow-up duration vary across studies. The consistent direction of the evidence is strongly favorable, and TMR is well established at peripheral nerve centers, but patients should understand that the evidence base, while solid and growing, continues to mature. The fact that the data are so heavily patient-reported is a genuine strength, because it reflects what matters to patients rather than only what is visible to surgeons.

Outcomes Beyond Pain

TMR's benefits extend past pain relief in two important ways.

Reduced opioid use. Multiple studies, including the oncologic cohort above, document meaningful reductions in opioid and pain-medication use after TMR. For a population historically reliant on opioids for amputation pain, this is a substantial benefit with implications well beyond the pain scores themselves.

Prosthetic control and function. Because TMR generates amplified, intuitive control signals from the reinnervated muscles, it is foundational to the most advanced myoelectric prosthetic devices. A patient who thinks about moving the missing hand sends a signal that the reinnervated muscle translates into prosthetic movement that feels natural. The functional studies show improvements in limb function scores, though it is worth noting that not every patient completes prosthetic rehabilitation — in one upper-extremity series, a portion of patients did not finish the rehabilitation process despite improved functional scores, a reminder that the surgery is one part of a larger rehabilitation effort.

Risks

TMR is generally well tolerated, with a risk profile similar to other peripheral nerve operations. Recognized risks include bleeding, infection, and the general risks of surgery and anesthesia; incomplete pain relief, since not every patient achieves complete relief and those with long-standing neuromas or significant central sensitization may improve only partially; the possibility of new or persistent pain at the surgical site; and a recovery period during which pain persists before the nerve reorganization produces relief, which patients should understand is expected rather than a sign of failure. When TMR is added at the time of amputation, it lengthens the operation somewhat.

No surgery for amputation-related pain guarantees complete relief. Honest counseling about the realistic range of outcomes — including the strong likelihood of meaningful improvement but the possibility of partial relief — is part of the decision to operate.

How the Decision Is Made

TMR is worth discussing for most patients facing a planned major limb amputation (where primary TMR can prevent neuroma pain) and for amputees living with established neuroma, residual limb, or phantom limb pain (where secondary TMR can treat it). Because the evidence so strongly favors performing nerve management at the time of amputation when possible, the ideal time to have this conversation is before a planned amputation, as part of the surgical planning — not after pain has developed.

The decision is best made with a surgeon experienced in peripheral nerve surgery, ideally within a team that includes the amputation surgeon, prosthetists, and rehabilitation specialists. TMR and the related RPNI technique are often used together or chosen based on the specific nerves and anatomy involved; a surgeon familiar with both can tailor the approach.

‍

Related Topics

• TMR vs. RPNI: what is the difference?
• What to expect after RPNI surgery for nerve pain
• Peripheral nerve surgery, RPNI, and TMR
• Nerve repair and reconstruction
• Replantation and revascularization

‍